| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | 17 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | - | 357 | 3.792 | 315 | 125 | 209 | 1 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | - | -339 | -3.792 | -314 | -125 | -209 | -1 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | - | -339 | -3.792 | -314 | -125 | -209 | -1 | 0 | 0 | 0 |
| Employees | - | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Neogenetics Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 117.216 | 125.593 | 123.288 | 120.900 | 118.608 | 115.978 | 116.338 | 115.985 | 115.337 |
| Current Assets | - | 31.652 | 31.085 | 30.480 | 29.911 | 29.332 | 28.681 | 28.770 | 28.683 | 28.522 |
| Inventories | - | 31.637 | 31.101 | 30.531 | 29.939 | 29.372 | 28.720 | 28.809 | 28.722 | 28.562 |
| Receivables | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | 16 | -16 | -51 | -28 | -39 | -39 | -40 | -39 | -39 |
| Shareholders Funds | - | -295 | -4.082 | -4.321 | -4.363 | -4.489 | -4.390 | -4.404 | -4.390 | -4.366 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 149.163 | 160.760 | 158.089 | 155.175 | 152.429 | 149.049 | 149.511 | 149.058 | 148.225 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Neogenetics Srl